Total planned funding: $521,285,783
Allocations
Countries/Regions
| Kenya | $117,047,857 |
| Nigeria | $65,439,010 |
| Ethiopia | $49,329,016 |
| South Africa | $48,999,782 |
| Uganda | $48,663,852 |
| Zambia | $43,608,772 |
| Mozambique | $32,854,027 |
| Tanzania | $30,247,385 |
| Rwanda | $15,547,187 |
| Zimbabwe | $11,045,023 |
| Côte d'Ivoire | $9,249,852 |
| Namibia | $8,889,584 |
| Lesotho | $7,779,374 |
| Eswatini | $4,666,649 |
| Botswana | $4,403,742 |
| Haiti | $3,617,365 |
| Malawi | $3,585,835 |
| Vietnam | $3,159,989 |
| Democratic Republic of the Congo | $2,066,191 |
| India | $1,922,131 |
| Cameroon | $1,456,720 |
| Cambodia | $1,138,805 |
| China | $1,112,650 |
| Russia | $1,100,000 |
| Ghana | $692,067 |
| Burundi | $660,000 |
| Dominican Republic | $625,000 |
| Guyana | $432,100 |
| South Sudan | $419,565 |
| Asia Regional Program | $394,492 |
| Indonesia | $312,100 |
| Caribbean Region | $304,056 |
| Central Asia Region | $300,000 |
| Thailand | $215,605 |
Organizational Types
| Unknown | $521,285,783 |
Program Areas
| Treatment | $521,285,783 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $381,739,337 |
| HTXD: Treatment: ARV Drugs | $80,257,547 |
| PDTX: Treatment: Pediatric Treatment | $59,288,899 |
Top Partner Programs
Not Available:
$521,285,783
View countries